LYEL · Lyell Immunopharma, Inc. · Executive Compensation
$8.96
+0.17 (+1.93%)
At close · Oct 9
Return incl. dividend (before tax)
Market Cap
$215.40M
Shares
24.51M
Volume · Oct 9
37.05K
Avg daily vol (3M)
145.6K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Lynn Seely | President, Chief Executive Officer and Director | $4,222,265 |
| Stephen Hill | Chief Operating Officer | $2,076,439 |
| Gary Lee | Chief Scientific Officer | $1,942,621 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Matthew Lang | Chief Business Officer | $1,869,632 |
| Lynn Seely | President, Chief Executive Officer and Director | $1,495,376 |
| Stephen Hill | Chief Operating Officer | $1,342,842 |
| Gary Lee | Chief Scientific Officer | $1,309,478 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Charles Newton | Chief Financial Officer | $4,317,424 |
| Matthew Lang | Chief Business Officer | $4,008,353 |
| Stephen Hill | Chief Operating Officer | $3,108,128 |
| Lynn Seely | President, Chief Executive Officer and Director | $2,647,476 |
| Tina Albertson | M.D., Ph.D. Former Chief Medical Officer and Head of Development | $2,391,403 |
| Gary Lee | Chief Scientific Officer | $2,226,356 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Lynn Seely | President, Chief Executive Officer and Director | $18,686,189 |
| Elizabeth Homans | Former Chief Executive Officer and Director | $12,119,604 |
| Gary Lee | Chief Scientific Officer | $4,128,472 |
| Stephen Hill | Chief Operating Officer | $4,068,026 |
| Rahsaan W. Thompson | Chief Legal Officer | $3,924,659 |
| Charles Newton | Chief Financial Officer | $3,875,468 |
| Tina Albertson | M.D., Ph.D. Former Chief Medical Officer and Head of Development | — |
| Matthew Lang | Chief Business Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Richard Klausner | M.D. Board Chair and former Executive Chairman | $33,366,629 |
| Charles Newton | Chief Financial Officer | $19,124,792 |
| Elizabeth Homans | Former Chief Executive Officer and Director | $18,643,569 |
| Stephen Hill | Chief Operating Officer | $2,384,118 |
| Matthew Lang | Chief Business Officer | — |
| Rahsaan W. Thompson | Chief Legal Officer | — |
| Lynn Seely | President, Chief Executive Officer and Director | — |
| Gary Lee | Chief Scientific Officer | — |
| Tina Albertson | M.D., Ph.D. Former Chief Medical Officer and Head of Development | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Richard Klausner | M.D. Board Chair and former Executive Chairman | $38,852,236 |
| Elizabeth Homans | Former Chief Executive Officer and Director | $18,869,275 |
| Stephen Hill | Chief Operating Officer | $2,856,657 |
| Rahsaan W. Thompson | Chief Legal Officer | — |
| Charles Newton | Chief Financial Officer | — |
| Lynn Seely | President, Chief Executive Officer and Director | — |
| Gary Lee | Chief Scientific Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Smital Shah | Chief Financial and Business Officer | Appointed | 2026-03-09 |
| Veronica Sanchez Bulis | principal accounting officer | Appointed | 2025-11-03 |
| Charles Newton | Chief Financial Officer and principal financial and accounting officer | Resigned | 2025-09-16 |
| Mark Bachleda | Class I director | Appointed | 2025-06-09 |
| Matthew Lang, J.D. | Chief Business Officer | Resigned | 2025-04-01 |
| Hans Bishop | member of the Board of Directors | Resigned | 2024-11-26 |
| Sumant Ramachandra | Lyell Board of Directors | Appointed | 2024-10-31 |
| Sumant Ramachandra, M.D., Ph.D. | Class III director | Appointed | 2024-10-31 |
| Lynn Seely | President and Chief Executive Officer | Appointed | 2022-12-16 |
| Elizabeth Homans | member of the Board of Directors | Resigned | 2022-12-16 |
| Elizabeth Homans | Chief Executive Officer | Resigned | 2022-12-16 |